Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01145807Phase 3Unknown
A Phase 3 trial of TDT-067 in onychomycosis, sponsored by Celtic Pharma. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01145807.